Search results
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 3 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 2 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoDuring the March quarter, the U...projection. The company also raised its sales outlook for the...
Analyst Report: Pfizer Inc.
Morningstar Research via Yahoo Finance· 2 days agoPfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically ...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 2 days agoPrevnar: The pneumococcal vaccine should continue being a cash cow for the drugmaker despite potential competition from Merck's vaccine V116 in the adult...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Supreme Court Rejects Military Chaplains' Lawsuit Claiming Refusal of COVID-19 Vaccine Hurt Their...
Military.com via Yahoo News· 4 days agoThe justices rejected a petition from 39 military chaplains who said they continue to face...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 2 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 2 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company ...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoI am pleased and appreciative of how our Pfizer colleagues are executing with discipline as they focus on the patients and others we serve. This helped...
